Home Cart 0 Sign in  

[ CAS No. 1192651-49-2 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 1192651-49-2
Chemical Structure| 1192651-49-2
Structure of 1192651-49-2 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1192651-49-2 ]

Related Doc. of [ 1192651-49-2 ]

Alternatived Products of [ 1192651-49-2 ]

Product Details of [ 1192651-49-2 ]

CAS No. :1192651-49-2 MDL No. :MFCD29472346
Formula : C14H17N3O3 Boiling Point : -
Linear Structure Formula :- InChI Key :HYTSWLKLRKLRHK-NEPJUHHUSA-N
M.W : 275.30 Pubchem ID :57389435
Synonyms :

Safety of [ 1192651-49-2 ]

Signal Word:Danger Class:4.1
Precautionary Statements:P240-P210-P241-P264-P280-P302+P352-P370+P378-P337+P313-P305+P351+P338-P362+P364-P332+P313 UN#:1325
Hazard Statements:H228-H315-H319 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 1192651-49-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 1192651-49-2 ]

[ 1192651-49-2 ] Synthesis Path-Downstream   1~12

  • 1
  • [ 1174020-25-7 ]
  • [ 1192651-49-2 ]
YieldReaction ConditionsOperation in experiment
80% With ammonium chloride; benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 17h; 8.1 DIPEA (5.8 mL, 36.2 mmol) was added to a solution of (2S,5R)-6-(benzyloxy)-7-oxo-1,6-diaza-bicyclo[3.2.1]octane-2-carboxylic acid (5.0 g, 18.1 mmol), EDCI (5.2 g, 27.2 mmol), HOBT (3.7 g, 27.2 mmol) and NH4Cl (1.94 g, 36.2 mmol) in DMF (60 mL) at rt. The reaction mixture was stiffed for 17 hrs, then diluted with ice water (100 mL) and extracted with EtOAc (3*). The combined organic layer was dried over Na2SO4, and concentrated. The residue was purified by silica gel column chromatography (2:1 EtOAc/petroleum ether) to afford (2S,5R)-6-(benzyloxy)-7-oxo-1,6-diaza-bicyclo[3.2.1]octane-2-carboxamide (4.0 g, 80%) as a white solid. ESI-MS (EI+, m/z): 276 [M+H]+.
79% Stage #1: (2S,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxylic acid With triethylamine; isobutyl chloroformate In dichloromethane at 0℃; for 0.333333h; Stage #2: With ammonia In dichloromethane; water at 20℃; for 1h; 22 Example 22; (2S,5R)-6-(Benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamide (F1-4) 400 mg (1.44 mmol) of (2S,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxylic acid was dissolved in dehydrated dichloromethane (14.4 mL), and 176 mg of triethylamine was added, followed by cooling to 0° C. 237 mg of isobutyl chloroformate was added to the mixture, followed by stirring at the same temperature for 20 minutes. 1.0 of concentrated aqueous ammonia was added to the reaction mixture, followed by stirring at room temperature for 1 hour. Subsequently, water (10 mL) was added and the organic layer was fractionated, followed by sequential washing with water and saturated brine and drying over anhydrous magnesium sulfate. The residue resulting from concentration of the solvent under reduced pressure was applied to silica gel column chromatography (hexane/ethyl acetate=1/3), and subsequently crystallized with chloroform/hexane=1:3 to afford 315 mg of the title compound as a colorless crystalline powder (yield 79%). Enantiomeric excess: 99.9% ee or more (CHIRALPAK A D-H, 4.6×150 mm, hexane/ethanol=4/1, UV 210 nm, flow rate mL/min., retention time 16.2 min.).Mp 169° C.; [α]20D -22.0° (c 1.26, MeOH); 1H NMR and MS equivalent to those of the title compound of Example 21.
79% Stage #1: (2S,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxylic acid With triethylamine; isobutyl chloroformate In dichloromethane at 0℃; for 0.333333h; Stage #2: With ammonium hydroxide In dichloromethane at 20℃; for 1h; 22 (2S,5R)-6-(Benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamide (F1-4) 400 mg (1.44 mmol) of (2S,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1] octane-2-carboxylic acid was dissolved in dehydrated dichloromethane (14.4 mL), and 176 mg of triethylamine was added, followed by cooling to 0°C. 237 mg of isobutyl chloroformate was added to the mixture, followed by stirring at the same temperature for 20 minutes. 1.0 mL of concentrated aqueous ammonia was added to the reaction mixture, followed by stirring at room temperature for 1 hour. Subsequently, water (10 mL) was added and the organic layer was fractionated, followed by sequential washing with water and saturated brine and drying over anhydrous magnesium sulfate. The residue resulting from concentration of the solvent under reduced pressure was applied to silica gel column chromatography (hexane/ethyl acetate=1/3), and subsequently crystallized with chloroform/hexane=1:3 to afford 315 mg of the title compound as a colorless crystalline powder (yield 79%). Enantiomeric excess: 99.9% ee or more (CHIRALPAK AD-H, 4.6 x 150 mm, hexane/ethanol=4/1, UV 210 nm, flow rate 1 mL/min., retention time 16.2 min.).In powder X-ray diffraction diagram, the crystal of the title compound demonstrated characteristic peak patterns as shown in the following Table 11. For measurement, RINT 2100 from Rigaku Corporation was used as a powder X-ray diffraction device, in which measurement was conducted with CuKα1 as an X-ray source, a tube voltage of 40 kV, a tube current of 40 mA, a scan speed of 4°/min., and a scan range of 2θ=3 to 40°. [Table 13] Powder X-ray Diffraction of Compound (F1-4) Peak Position Relative Intensity 2θ Spacing (d) (Cuka) Å I/I0 6.76 13.06 100 13.58 6.52 23 17.24 5.14 48 18.70 4.74 34 19.16 4.63 13 20.46 4.34 45 23.08 3.85 17 23.92 3.72
Multi-step reaction with 2 steps 1.1: 4-methyl-morpholine; isobutyl chloroformate / dichloromethane / 0 °C 1.2: 0.5 h 2.1: ammonia / dichloromethane; water / 1 h / 0 - 20 °C
Multi-step reaction with 2 steps 1.1: 4-methyl-morpholine; isobutyl chloroformate / dichloromethane / 0.17 h / 0 °C 1.2: 0.5 h 2.1: ammonium hydroxide / dichloromethane / 1 h / 0 - 20 °C
With ammonium hydroxide; triethylamine; isobutyl chloroformate In dichloromethane at -10 - 20℃; for 1h; 3 Example 3. Synthesis of Intermediate IV Add 6L of dichloromethane and 300g of Intermediate III to a 20L reactor, stir to dissolve, add 164.8g of triethylamine, and cool to below -10°C. Add 222.5g isobutyl chloroformate dropwise below -5°C, continue to cool to below -10°C after the dropwise addition is complete, add 0.9L ammonia water dropwise below -10°C, and stir at room temperature for 1h after the dropwise addition is complete. Add 3.0L of drinking water, stand still and separate into layers to take the organic layer, wash the organic layer with 1N hydrochloric acid and saturated brine successively, take the organic layer, dry with anhydrous sodium sulfate, filter, and distill the filtrate under reduced pressure at 3540, add 6L dropwise N-heptane was stirred and crystallized at 20-25°C for 2h, filtered and dried to obtain an off-white solid with a yield of 75-85%.

  • 2
  • [ 1192651-49-2 ]
  • [ 10534-59-5 ]
  • [ 1416134-53-6 ]
YieldReaction ConditionsOperation in experiment
92% Stage #1: (1R,2S,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamide With hydrogen; sulfur trioxide trimethylamine complex; triethylamine In water; isopropyl alcohol Stage #2: tetrabutylammonium acetate In water; isopropyl alcohol 4.4a Example 4aTetrabutylammonium ([(2S,5R)-2-carbamoyl-7-oxo-1,6-diazabicyclo[3.2.1]oct-6-yl]oxy}sulphonyl]oxidanide was prepared as described below.(2S,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamide (10 g, 36.2 mmol, 1 eq) was mixed with sulfur trioxide trimethylamine complex (6.07 g, 43.44 mmol, 1.2 eq), triethylamine (1.3 ml, 18 mmol, 0.25 eq), palladium on carbon (0.8 g, 10% palladium, 50% water), isopropanol (50 ml) and water (50 ml). This mixture was treated with hydrogen until the reaction was deemed to be complete. The catalyst was removed by filtration and washed with water (20 ml). The combined filtrates were washed with n-BuOAc (70 ml, 20 ml) before a solution of tetrabutylammonium acetate (54.5 mmol) in water (20 ml) was added. The product was extracted with dichloromethane (100 ml, 50 ml) and solvent swapped into 4-methyl-2-pentanone, before filtering, washing and drying to yield a white crystalline solid (16.9 g, 92%).1H NMR (400 MHz, CDCl3) δH 1.00 (12H, t), 1.45 (8H, m), 1.67 (9H, m), 1.87 (1H, m), 2.16 (1H, m), 2.37 (1H, dd), 2.87 (1H, d), 3.31 (9H, m), 3.91 (1H, d), 4.33 (1H, s), 5.79 (1H, s), 6.67 (1H, s).
89.6% Stage #1: (1R,2S,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamide With palladium 10% on activated carbon; hydrogen; sulfur trioxide trimethylamine complex; triethylamine In water; isopropyl alcohol Stage #2: tetrabutylammonium acetate With acetic acid In water; isopropyl alcohol
85% Stage #1: (1R,2S,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamide With formic acid; palladium on activated charcoal; ammonium formate In isopropyl alcohol at 35℃; Stage #2: tetrabutylammonium acetate In water at 20℃; for 3h; 5 Example 5 Preparation of (Compound K) ([(2S,5R)-2-carbamoyl-7-oxo-6-(sulfooxy)-1,6-diazabicyclo)[3,2,1]-oct-6-yl]oxy}sulfonyl)tetrabutylammonium salt: Isopropanol (9000 ml) was added to the reaction flask, and compound J (600.0 g), palladium on carbon (60.0 g), ammonium formate (68.7 g) and formic acid (200.5 g) were added.The reaction temperature was controlled at 30 ° C to 35 ° C for 2 to 3 hours, and the J reaction was completely detected by HPLC, followed by suction filtration and washing.Triethylamine (55.0 g) and trimethylamine trioxide (424.6 g) were added to the filtrate.The temperature is controlled at 30 ° C to 35 ° C, and the reaction is stirred for 3 to 4 hours.An aqueous solution of 35% tetrabutylammonium acetate (821.4 g) was added thereto, and the reaction was stirred at room temperature for 3 hours, and the reaction liquid was concentrated to 10 kg.Dichloromethane (3.6 kg X2) was added to the concentrated reaction mixture for 2 times. After phase separation, the organic phase was concentrated under vacuum at 40 to 50 ° C to give an oil.After adding 1800 ml of methyl isobutyl ketone, the mixture was subjected to crystallization, suction filtration, washing and drying to obtain 938.4 g of the title compound K. The yield was 85.0%, the purity was 99.7%, and the single impurity was <0.1%.
79.6% Stage #1: (1R,2S,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamide With palladium 10% on activated carbon; hydrogen; triethylamine In water; isopropyl alcohol Stage #2: tetrabutylammonium acetate In water 8 8, Preparation of (2S,5R)-1,6-diazacyclo[3.2.1]octane-2-carboxamide-7-oxo-6-sulfonate-tetrabutylammonium salt (9) Add (2S,5R)-6-benzyloxy-7-oxo-1,6-diazacyclo[3.2.1]octane-2-formamide (8) (10 g, 36.2 mmol) was added to a 250 ml single-mouth bottle, trimethylamine sulfur trioxide copolymer (6.07 g, 43.44mmol), triethylamine (1.3 ml,18 mmol), palladium on carbon (0.8 g, 10%), followed by isopropanol (50 ml) and water (50 ml), the reaction was completed to completion under hydrogen. The solid was removed by suction filtration, and the filtrate was added n-butyl acetate (70 ml, 20 ml), and the mixture was separated. Tetrabutylammonium acetate (16.4 g,54.5 mmol) was dissolved in water (20 ml) and slowly added dropwise to the obtained aqueous phase. After stirring until the reaction is completed, dichloromethane is added to separate the organic layer, which is dried over anhydrous sodium sulfate, and then filtered and evaporated to remove methylene chloride, then 4-methyl-2-pentanone (25 ml), and cooled to Stir at 0 °C, suction and dry to give a white solid (2S,5R)-1,6-diazacyclo[3.2.1]octane-2-carboxamide-7-oxo-6-sulfonyl-tetrabutyl The ammonium salt (9) (14.6 g, 79.6%).

  • 4
  • [ 1416134-49-0 ]
  • [ 530-62-1 ]
  • [ 1192651-49-2 ]
YieldReaction ConditionsOperation in experiment
90% Stage #1: (2S,5R)-5-(benzyloxyamino)-piperidine-2-carboxylic acid amide With (fluorenylmethoxy)carbonyl chloride; N-ethyl-N,N-diisopropylamine In chlorobenzene at 30℃; Stage #2: 1,1'-carbonyldiimidazole In chlorobenzene Stage #3: With diethylamine In chlorobenzene 3.3a Example 3a(2S,5R)-5-[(benzyloxy)amino]piperidine-2-carboxamide (102 g, 409 mmol) was mixed with di-isopropylethylamine (76.2 ml, 437.6 mmol) and chlorobenzene (612 ml) at 20° C. 9-fluorenylmethyl chloroformate (107.9 g, 417.2 mmol) as a solution in chlorobenzene (612 ml) was added to the reaction mixture, and the mixture was stirred at 30° C. until the reaction was complete. Carbonyl diimidazole (86.2 g, 531.7 mmol) was added and agitation was continued until the reaction was deemed to be complete. Diethylamine (105.8 ml, 1022.5 mmol) was added and agitation was continued until the reaction was deemed to be complete. Aqueous hydrochloric acid (640 ml, 3N, 1920 mmol) was added and the mixture was cooled to 2° C. The solid was isolated by filtration, washed with water (2×200 ml) and 1-chlorobutane (2×200 mL) and dried to give the title compound as a white crystalline solid (101 g, 367.2 mmol, 90%).1H NMR (400 MHz, DMSO) δH 1.65 (2H, m), 1.83 (1H, m), 2.07 (1H, m), 2.91 (2H, s), 3.63 (1H, s), 3.69 (1H, d), 4.92 (1H, d), 4.96 (1H, d), 7.38 (7H, m).
89% Stage #1: (2S,5R)-5-(benzyloxyamino)-piperidine-2-carboxylic acid amide With (fluorenylmethoxy)carbonyl chloride; N-ethyl-N,N-diisopropylamine In chlorobenzene at 20 - 30℃; Stage #2: 1,1'-carbonyldiimidazole In chlorobenzene at 15℃; for 11h; Stage #3: With diethylamine In chlorobenzene at 20℃; for 2h;
495 g Stage #1: (2S,5R)-5-(benzyloxyamino)-piperidine-2-carboxylic acid amide With (fluorenylmethoxy)carbonyl chloride; N-ethyl-N,N-diisopropylamine In chlorobenzene at 20 - 30℃; Stage #2: 1,1'-carbonyldiimidazole In chlorobenzene at 15℃; for 11h; Stage #3: With diethylamine In chlorobenzene at 15 - 20℃; for 2h;
  • 7
  • [ 77925-80-5 ]
  • [ 1192651-49-2 ]
  • 8
  • [ 32315-10-9 ]
  • [ 1416134-49-0 ]
  • [ 1192651-49-2 ]
YieldReaction ConditionsOperation in experiment
64% Stage #1: bis(trichloromethyl) carbonate; (2S,5R)-5-(benzyloxyamino)-piperidine-2-carboxylic acid amide With potassium carbonate In dichloromethane at -10℃; for 1h; Stage #2: With dmap In dichloromethane at 20℃; for 24h; 5 Production process for 7-oxo-6-benzyloxy-1,6-diazabicylco-[3.2.1]octane-2-carboxylic acid amide (2S,5R)-5-(benzyloxyamino)-piperidine-2-carboxylic acid amide (118 mg, 0.475 mmol), potassium carbonate (372 mg, 2.69 mmol), and dichloromethane (10 mL) were cooled to -10°C, followed by addition of triphosgene (117 mg, 0.394 mmol). Stirring at -10°C for 1 hour was followed by addition of N,N-dimethylaminopyridine (2.3 mg, 0.019 mmol) and further stirring at room temperature for 1 day. The reaction solution was concentrated, to which ethyl acetate (10 mL) and water (2 mL) were added, and the resultant mixture was removed from aqueous layer. The organic layer was dried with anhydrous sodium sulfate, followed by concentration under reduced pressure, to obtain the title compound (83.3 mg, 64% yield). 1H NMR (500 MHz, CDCl3): 7.34-7.44 (m, 5H), 6.69 (s, 1H), 6.20 (s, 1H), 5.05 (d, J = 11.5 Hz, 1H), 4.91 (d, J = 11.5 Hz, 1H), 3.94 (d, J = 8.5 Hz, 1H), 3.32 (s, 1H), 3.03 (d, J = 11.5 Hz, 1H), 2.78 (d, J = 11.5 Hz, 1H), 2.33 (dd, J = 14.5, 7.0 Hz, 1H), 1.88-2.02 (m, 2H), 1.58-1.64 (m, 1H).
  • 9
  • [ 28920-43-6 ]
  • [ 1416134-49-0 ]
  • [ 1192651-49-2 ]
YieldReaction ConditionsOperation in experiment
89% Stage #1: (fluorenylmethoxy)carbonyl chloride; (2S,5R)-5-(benzyloxyamino)-piperidine-2-carboxylic acid amide In chlorobenzene at 20℃; Stage #2: With 1,1'-carbonyldiimidazole In chlorobenzene at 20℃; Stage #3: With diethylamine In chlorobenzene for 2h; 7 7, Preparation of (2S,5R)-6-benzyloxy-7-oxo-1,6-diazacyclo[3.2.1]octane-2-carboxamide (8) (2S,5R)-5-benzyloxyamino-2-piperidinecarboxamide (7) (51 g, 204.5 mmol) was added to a 1 L three-necked flask. Diisopropylamine (38.1 ml, 218.8 mmol) and chlorobenzene (306 ml), The methoxycarbonyl chloride (54 g, 208.6 mmol) was dissolved in chlorobenzene (306 ml). Slowly drip it into the reaction solution at 20 °C, The reaction was stirred to completion at room temperature. N,N'-carbonyldiimidazole (33.1 g, 265.8 mmol) was added to the reaction solution. Stir at room temperature until the reaction is complete. Diethylamine (52.9 ml, 511.2 mmol) was added dropwise to the reaction solution. After stirring for 2 hours, Dilute hydrochloric acid (320 ml, 3N, 960 ml) was added dropwise to the reaction mixture. The mixture was cooled to 0 °C and stirred for 1 h. Filtered to a solid, Washed twice, Drying in a vacuum oven for 2 h gave (2S,5R)-6-benzyloxy-7-oxo-1,6-diazacyclo[3.2.1]octane-2-carboxamide (8) (49.5 g, 89%).
  • 10
  • [ 1416134-49-0 ]
  • chloroformic acid 9-decane ester [ No CAS ]
  • [ 1192651-49-2 ]
YieldReaction ConditionsOperation in experiment
90% Stage #1: (2S,5R)-5-(benzyloxyamino)-piperidine-2-carboxylic acid amide; chloroformic acid 9-decane ester With diisopropylamine In chlorobenzene at 20 - 30℃; Stage #2: With diethylamine; 1,1'-carbonyldiimidazole In chlorobenzene 1 Example 1 Preparation of (Compound J) (2S,5R)-6-Benzyloxy-7-oxo-6-(sulfooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide:(Refer to patent document CN103649051) (2S,5R)-5-[(Benzyloxy)amino]piperidine-2-carboxamide (102 g, 409 mmol) and diisopropylamine (76.2 ml, 437.6 mmol) and chlorine at 20 °C The benzene (612 ml) was mixed.A solution of 9-decyl chloroformate (107.9 g, 417.2 mmol) as chlorobenzene (612 ml) was added to the reaction mixture, and the mixture was stirred at 30 ° C until the reaction was completed.Carbonyldiimidazole (86.2 g, 531.7 mmol) was added and stirring was continued until the reaction was deemed complete.Diethylamine (105.8 ml, 1022.5 mmol) was added and stirring was continued until the reaction was deemed complete.Aqueous hydrochloric acid (640.0 ml, 3N, 1920 ml) was added and the mixture was cooled to 2 °C.The solid was isolated by filtration, washed with water (2×, 200 mL) and dried.The title compound (101 g, 367.2 mmol, 90%) was obtained as white crystals.
  • 11
  • [ 32315-10-9 ]
  • [ 1416134-48-9 ]
  • [ 1192651-49-2 ]
YieldReaction ConditionsOperation in experiment
90.5% To a 500 ml four-necked flask equipped with a stirring, a thermometer was charged with 150 g of dichloromethane, 120 g of a 10% strength aqueous sodium hydroxide solution, and 37.0 g (0.1 mol) of 5R-benzyloxyaminopiperidine- 2S-ethyl formate oxalate (III) was stirred at 20-25 C for 4 hours. It was acidified with a 30% aqueous solution of hydrochloric acid to a pH of 2.5-3.0, stirred at room temperature for 1-2 hours; layered, and the aqueous layer was extracted three times with dichloromethane, 50 g each time. Combine the organic phase to obtain a mixed organic phase;
  • 12
  • [ 1192651-49-2 ]
  • [ 32503-27-8 ]
  • [ 1416134-53-6 ]
YieldReaction ConditionsOperation in experiment
95% Stage #1: (1R,2S,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamide With palladium on activated charcoal; hydrogen; sulfur trioxide trimethylamine complex; triethylamine In water; isopropyl alcohol at 35℃; for 0.0166667h; Flow reactor; Large scale; Stage #2: tetra(n-butyl)ammonium hydrogensulfate In water Large scale; 1; 2; 1.1; 1.2; 1.3; 1.4; 1.5; 2.1; 2.2; 2.3; 2.4; 2.5; 3.1; 3.2; 3.3; 3.4; 3.5; 4.1; 4.2; 4.3; 4.4; 4.5 ([((2S, 5R) -2-carbamoyl-7-oxo-6- (sulfooxy) -1,6-diazabicyclo [3,2,1] -octane-6- Of phenyl] oxy} sulfonyl) tetrabutylammonium (Compound III) (1) Add isopropyl alcohol (10L) and purified water (10L) to the reaction flask, add compound II (2kg), sulfur trioxide trimethylamine copolymer (2kg), triethylamine (600g), and palladium carbon (200.0 g), stir evenly at room temperature and set aside.(2) Using Corning G4 reactor, the hydrogen pressure is set to 0.5MPa, the hydrogen flow rate is 15NL / min (0.67mol / min), and the feed rate is 1.2kg / min (0.39mol / min based on intermediate II) The reaction temperature is set to 35 ° C, and the equipment runs stably.(3) Turn on the feed pump and inject the reaction material into the reactor through the feed pump to start the reaction. After about 1 minute, the reaction solution flows out of the reactor to the material collection tank.(4) Filter and collect the filtrate, add tetrabutylammonium hydrogen sulfate (3kg) aqueous solution to the filtrate and stir well, and finally add dichloromethane to stir vigorously and extract.The organic phase was collected after liquid separation and concentrated to give the crude compound III as an oil.(5) Add methyl tert-butyl ether to the crude product III and stir for crystallization, filter and collect the filter cake, and obtain compound III after drying; the yield is 95.0%, and the purity is 99.4%.
Same Skeleton Products
Historical Records